Spontaneously acquired anti-factor VIII antibodies: report of a patient with adenocarcinoma of the prostate.

Published

Journal Article

Anti-factor VIII antibodies, inherited or acquired inhibitors of the factor VIII molecule, have not been reported previously in the urological literature. Although more common in hemophiliac patients who have received multiple transfusions, this anticoagulant may be the cause of severe hemorrhage in nonhemophiliac patients. We describe a patient with carcinoma of the prostate and an unsuspected anti-factor VIII antibody, who experienced excessive postoperative bleeding and prolonged hospitalization following a vesicolithotomy and bilateral orchiectomy. A prolonged partial thromboplastin time and a significant decrease in measurable factor VIII clotting activity in a patient with no history of bleeding problems are essential clues in making the diagnosis of a factor VIII inhibitor. This coagulation defect is treated best with prothrombin complex concentrates, which contain vitamin K dependent clotting factors.

Full Text

Duke Authors

Cited Authors

  • Preminger, GM; Knupp, CL; Hindsley, JP; Jenkins, JM; Fried, FA; Blatt, PM

Published Date

  • June 1, 1984

Published In

Volume / Issue

  • 131 / 6

Start / End Page

  • 1182 - 1184

PubMed ID

  • 6427480

Pubmed Central ID

  • 6427480

International Standard Serial Number (ISSN)

  • 0022-5347

Digital Object Identifier (DOI)

  • 10.1016/s0022-5347(17)50864-2

Language

  • eng

Conference Location

  • United States